Search research articles
Contact Us
Filters
Showing results (51-60 of 114) with videos related to
Page
of 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
April 19, 2017
High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges
Anton W Langerak, Monika Brüggemann, Frédéric Davi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2023
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial
Eva Hoster, Marie-Hélène Delfau-Larue, Elizabeth Macintyre, et al.
Leukemia
|
August 16, 2022
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
Heiner Zimmermann, Christian Koenecke, Martin H Dreyling, et al.
British Journal of Haematology
|
November 20, 2008
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma
Inga Vater, Florian Wagner, Markus Kreuz, et al.
International Journal of Cancer
|
July 9, 2020
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial
Tobias Roider, Xi Wang, Katrin Hüttl, et al.
British Journal of Haematology
|
June 25, 2015
Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations
Sietse M Aukema, Laura Theil, Marius Rohde, et al.
Leukemia
|
June 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
Lorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
The New England Journal of Medicine
|
March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Constantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
Blood
|
January 29, 2021
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
Lorenz Thurner, Natalie Fadle, Jörg Thomas Bittenbring, et al.
Hemasphere
|
November 15, 2019
Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study
Klaus Herfarth, Peter Borchmann, Sven Schnaidt, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 114) with videos related to
Sort By:
Page
of 12
Journal of Immunology (Baltimore, Md. : 1950)
|
April 19, 2017
High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges
Anton W Langerak, Monika Brüggemann, Frédéric Davi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2023
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial
Eva Hoster, Marie-Hélène Delfau-Larue, Elizabeth Macintyre, et al.
Leukemia
|
August 16, 2022
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
Heiner Zimmermann, Christian Koenecke, Martin H Dreyling, et al.
British Journal of Haematology
|
November 20, 2008
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma
Inga Vater, Florian Wagner, Markus Kreuz, et al.
International Journal of Cancer
|
July 9, 2020
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial
Tobias Roider, Xi Wang, Katrin Hüttl, et al.
British Journal of Haematology
|
June 25, 2015
Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations
Sietse M Aukema, Laura Theil, Marius Rohde, et al.
Leukemia
|
June 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
Lorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
The New England Journal of Medicine
|
March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Constantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
Blood
|
January 29, 2021
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
Lorenz Thurner, Natalie Fadle, Jörg Thomas Bittenbring, et al.
Hemasphere
|
November 15, 2019
Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study
Klaus Herfarth, Peter Borchmann, Sven Schnaidt, et al.
Page
of 12